Ice Cure Medical Ltd. ICCM
We take great care to ensure that the data presented and summarized in this overview for IceCure Medical Ltd. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding ICCM
View all-
Xtx Topco LTD London, X058.9KShares$75,9370.01% of portfolio
-
Geode Capital Management, LLC Boston, MA40.5KShares$52,1840.0% of portfolio
-
Two Sigma Securities, LLC New York, NY17KShares$21,9230.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny10.9KShares$14,0610.0% of portfolio
-
Concurrent Investment Advisors, LLC Tampa, FL10KShares$12,9000.0% of portfolio
-
Morgan Stanley New York, NY6.07KShares$7,8290.0% of portfolio
-
Jpmorgan Chase & CO New York, NY5.95KShares$7,6750.0% of portfolio
-
Avion Wealth The Woodlands, TX2.5KShares$3,2250.0% of portfolio
-
Bank Of America Corp Charlotte, NC862Shares$1,1110.0% of portfolio
-
Royal Bank Of Canada Toronto, A6500Shares$6450.0% of portfolio
Latest Institutional Activity in ICCM
Top Purchases
Top Sells
About ICCM
IceCure Medical Ltd, a medical device company, engages in the research, development, and commercialization of medical devices for cryoablation (freezing) of tumors in the human body. It offers ProSense system, a cryoablation solution for the treatment of breast tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.
Insider Transactions at ICCM
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|